Regeneron R3767-ONC
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 1, 2023
End Date
November 17, 2027
Administered By
Duke Cancer Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 1, 2023
End Date
November 17, 2027